Peter L Perrotta
Overview
Explore the profile of Peter L Perrotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sasi R, Senft J, Spruill M, Rej S, Perrotta P
Mol Cytogenet
. 2020 Apr;
13:14.
PMID: 32322307
Background: Constitutional heterologous double Robertsonian translocations (DRT) between chromosomes 13/14 and chromosomes 14/15 with 44 chromosomes are extremely rare. In this case report, we present the karyotype analysis of metaphases...
12.
Schifman R, Perrotta P, Blond B
Arch Pathol Lab Med
. 2019 Aug;
143(9):1045-1046.
PMID: 31453732
No abstract available.
13.
Novis D, Nelson S, Blond B, Guidi A, Talbert M, Mix P, et al.
Arch Pathol Lab Med
. 2019 Jul;
144(3):350-355.
PMID: 31313958
Context.—: Knowledge of laboratory staff turnover rates are important to laboratory medical directors and hospital administrators who are responsible for ensuring adequate staffing of their clinical laboratories. The current turnover...
14.
Bowman Z, Fei N, Ahn J, Wen S, Cumpston A, Shah N, et al.
Eur J Haematol
. 2019 Jan;
102(5):383-388.
PMID: 30664281
Objectives: Although hemoglobin thresholds for red blood cell (RBC) transfusion have decreased, double-unit RBC transfusion practices persist. We studied the effects switching from predominantly double-unit to single-unit RBC transfusions had...
15.
Schifman R, Perrotta P, Souers R, Blond B
Arch Pathol Lab Med
. 2018 Sep;
143(2):151-156.
PMID: 30203988
Context.—: Managing the utilization of laboratory tests is an important quality improvement activity that adds value to health care. Objective.—: To examine utilization of 3 laboratory tests and identify factors...
16.
Ducatman A, Tacker D, Ducatman B, Long D, Perrotta P, Lawther H, et al.
Acad Pathol
. 2017 Jul;
4:2374289517707506.
PMID: 28725791
Laboratory data are critical to analyzing and improving clinical quality. In the setting of residual use of creatine kinase M and B isoenzyme testing for myocardial infarction, we assessed disease...
17.
Perrotta P, Karcher D
Arch Pathol Lab Med
. 2016 Aug;
140(9):926-31.
PMID: 27575266
Context: -Laboratories must ensure that the test results and pathology reports they transmit to a patient's electronic health record (EHR) are accurate, complete, and presented in a useable format. Objective:...
18.
Darcy T, Barasch S, Souers R, Perrotta P
Arch Pathol Lab Med
. 2016 Feb;
140(2):125-9.
PMID: 26910216
Context: Requests for laboratory testing are canceled after a specimen has already been collected from the patient for many reasons. Regardless of the cause, test cancellation represents a significant resource...
19.
Smolkin M, Almubarak M, Perrotta P
W V Med J
. 2015 Nov;
111(5):40-5.
PMID: 26521535
Molecular testing of non-small cell lung carcinomas (NSCLCC) with adenocarcinoma features has become commonplace with the development and use of targeted treatments for these malignancies. Prior to treating these tumors...
20.
Meier F, Souers R, Howanitz P, Tworek J, Perrotta P, Nakhleh R, et al.
Arch Pathol Lab Med
. 2015 Jun;
139(6):762-75.
PMID: 26030245
Context: Many production systems employ standardized statistical monitors that measure defect rates and cycle times, as indices of performance quality. Clinical laboratory testing, a system that produces test results, is...